Olmesartan Drug Interactions

Brand name
  • Benicar
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated Details about this page

About Olmesartan

Olmesartan is an angiotensin II receptor antagonist used to treat high blood pressure in adults and children.

Read the full Olmesartan drug information page 

The Bottom Line on Olmesartan

Olmesartan's interactions most often show up as blood pressure changes, so you might feel dizzy, lightheaded or faint, and the kidneys can be affected too. It is a blood pressure medicine that works by relaxing and widening your blood vessels, and it is used in adults and children.

It has about as many documented interactions as a typical medicine, and some of them are rated serious. Lisinopril is one of them: taken together, the two can cause low blood pressure, fainting, high potassium and changes in how the kidneys work. If you notice anything new after starting something else alongside olmesartan, tell your pharmacist or doctor.

From the HelloPharmacist Editorial Team Written with AI from this page's interaction records · How we build these pages · How we use AI · Our editorial policy

Check Olmesartan Against Another Drug or Supplement

Type a drug, a brand name or a supplement. We check it against every documented olmesartan interaction, supplements and herbs included.

    What Could Happen When Olmesartan Interacts

    What the 98 documented olmesartan interaction records say could happen, grouped by the problem each one names. Tap a bar to see those drugs.

    This chart covers drug interactions only. Interactions with supplements and herbs are studied far less, so they are not counted here; they have their own pages on this site. One interaction can name more than one problem, so the numbers add up to more than 98.

    Olmesartan Interactions by Severity

    Moderate

    How Drug Interactions Work New to drug interactions? Six short figures, about a minute, show what can happen when Olmesartan meets another medicine: a level that rises or falls, or effects that add up. See how it works 

    Look Up Another Drug

    Still Have Questions About Olmesartan?

    Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

    About This Library

    Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

    What Each Rating Means

    Severity Levels

    • Contraindicated These should generally not be used together.
    • Major Potentially serious — often needs a change or close monitoring.
    • Moderate Can be significant — usually manageable with monitoring.
    • Minor Usually limited clinical impact.
    Back to the answer

    The References Behind Olmesartan’s Interactions

    The 98 sources our olmesartan interaction records cite: clinical studies, case reports and FDA prescribing information. Each pair's page lists the ones it rests on, numbered in its text, and a source link is one we checked against PubMed or Crossref. How we check them →

    1. Haller H, Ito S, Izzo JL Jr, et al: Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes. N Engl J Med 2011; 364(10):907-917.
    2. Imai E, Chan JC, Ito S, et al: Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study. Diabetologia 2011; 54(12):2978-2986. PubMed 
    3. Jones DW, Ferdinand KC, Taler SJ, et al: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM guideline for the prevention, detection, evaluation and management of high blood pressure in adults. Circulation 2025; 152(11):e114-e218.
    4. Kidney Disease Improving Global Outcomes (KDIGO) CKD Work Group: KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl 2013; 3(1):1-150.
    5. Product Information: BENICAR(R) oral tablets, olmesartan medoxomil oral tablets. Daiichi Sankyo (per FDA), Basking Ridge, NJ, 2019. DailyMed 
    6. Product Information: BENICAR(R) oral tablets, olmesartan medoxomil oral tablets. Daiichi Sankyo (per manufacturer), Basking Ridge, NJ, 2017. DailyMed 
    7. Izzo JL, Neutel JM, Silfani T, et al: Efficacy and safety of treating stage 2 systolic hypertension with olmesartan and olmesartan/HCTZ: results of an open-label titration study. J Clin Hypertens 2007; 9(1):36-44. PubMed 
    8. Barrios V, Boccanelli A, Ewald S, et al: Efficacy and tolerability of olmesartan medoxomil in patients with mild to moderate essential hypertension: the OLMEBEST Study. Clin Drug Investig 2007; 27(8):545-558. DOI 
    9. de la Sierra A, Armario P, Oliveras A, et al: Antihypertensive drug use in resistant and nonresistant hypertension and in controlled and uncontrolled resistant hypertension. J Hypertens 2018; 36(7):1563-1570. PubMed 
    10. Sakata Y, Shiba N, Takahashi J, et al: Clinical impacts of additive use of olmesartan in hypertensive patients with chronic heart failure: the supplemental benefit of an angiotensin receptor blocker in hypertensive patients with stable heart failure using olmesartan (SUPPORT) trial. Eur Heart J 2015; 36(15):915-923.

    Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.